KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $4.76.

  • Medpace Holdings' EPS (Basic) rose 2592.59% to $4.76 in Q4 2025 from the same period last year, while for Dec 2025 it was $15.64, marking a year-over-year increase of 1975.5%. This contributed to the annual value of $15.64 for FY2025, which is 1975.5% up from last year.
  • According to the latest figures from Q4 2025, Medpace Holdings' EPS (Basic) is $4.76, which was up 2592.59% from $3.95 recorded in Q3 2025.
  • Over the past 5 years, Medpace Holdings' EPS (Basic) peaked at $4.76 during Q4 2025, and registered a low of $1.11 during Q2 2021.
  • Moreover, its 5-year median value for EPS (Basic) was $2.33 (2023), whereas its average is $2.53.
  • The largest annual percentage gain for Medpace Holdings' EPS (Basic) in the last 5 years was 6323.53% (2021), contrasted with its biggest fall of 279.72% (2021).
  • Medpace Holdings' EPS (Basic) (Quarter) stood at $1.39 in 2021, then skyrocketed by 56.83% to $2.18 in 2022, then rose by 16.97% to $2.55 in 2023, then soared by 48.24% to $3.78 in 2024, then grew by 25.93% to $4.76 in 2025.
  • Its EPS (Basic) was $4.76 in Q4 2025, compared to $3.95 in Q3 2025 and $3.16 in Q2 2025.